NCT03568656
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03568656
Title Study to Evaluate CCS1477 in Advanced Tumours
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors CellCentric Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | GBR | FRA | ESP

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Institute Bergonie Bordeaux 33000 France Details
Hôpital Europeen Georges Pompidou Paris 75015 France Details
Institute Gustave Roussy Villejuif 94805 France Details
Netherlands Cancer Institute (NKI) Amsterdam 1066 CX Netherlands Details
Hospital Vall d'Hebron, VHIO Barcelona 08035 Spain Details
START CIOCC Hospital Universitario HM Madrid 28050 Spain Details
Karolinska Institute Stockholm 171 76 Sweden Details
Belfast City Hospital Belfast BT9 7AB United Kingdom Details
Queen Elizabeth Hospital Cancer Centre Birmingham B15 2TH United Kingdom Details
Cambridge University Hospital Cambridge CB2 0QQ United Kingdom Details
Edinburgh Cancer Centre Western General Hospital Edinburgh EH4 2XU United Kingdom Details
The Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
Leicester Royal Infirmary Leicester LE1 5WW United Kingdom Details
The Christie Hospital Manchester M20 4BX United Kingdom Details
Freeman Hospital Newcastle NE7 7DN United Kingdom Details
University Hospital Southampton Southampton SO16 6YD United Kingdom Details
Royal Marsden Hospital Sutton SM2 5NG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field